Injective (INJ) is currently trading at $3.03, reflecting a slight decline of 0.66% over the last 24 hours. The daily price range has been relatively tight, with a high of $3.15 and a low of $2.99, indicating limited volatility in the short term.

The trading volume stands at approximately 37.4 million, translating to a volume-to-market cap ratio of 12.35%. This level of volume suggests moderate interest among traders, but not enough to spark significant price movement in either direction.

Short-term moving averages indicate mixed sentiment; the 8 SMA at $3.02 is slightly bullish with a 0.40% increase, while the longer 144 SMA at $3.13 is bearish, down 3.23%. The 1-hour RSI at 29 indicates that INJ is currently oversold, while the 7-day RSI at 46 suggests that it is nearing a neutral level, hinting at potential for a price correction upward if buying pressure increases.

From a broader perspective, the 7-day price change of approximately 2.94% indicates a recent upward movement, contrasting sharply with the significant declines of 25.64% and 46.43% over the 14-day and 30-day periods respectively. This reflects an ongoing downtrend that may continue unless there are catalysts to reverse the sentiment.

Considering the technical indicators and recent price action, the current price level appears to be near support but lacks strong buying momentum. Therefore, the recommendation is to Hold at this moment, observing for potential bullish signals or a reversal pattern in the near term before considering a Buy.